Abbott's diversified portfolio (medical devices, diagnostics, nutrition, established pharmaceuticals) provides durable mid-single-digit organic growth with leadership positions in continuous glucose monitoring (FreeStyle Libre), structural heart, and electrophysiology. Libre 3 momentum continues; expansion into Type 2 non-insulin users via OTC Lingo is incremental TAM. Diagnostics normalized post-COVID. Nutrition recovery from Sturgis recall complete.
Thesis reviewed May 29, 2026
Abbott Laboratories is headquartered in United States, which is currently showing moderate signals.
🇺🇸United States48EARLYView United States risk detail →🏥Healthcare24NEUTRAL| Ticker | Company | Score | Gap | Signal Δ | Action |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Ltd. | 29 | +9% | ↓3% | NEUTRAL |
| UNH | UnitedHealth Group Inc. | 29 | +16% | ↓3% | AVOID |
| CVS | CVS Health Corporation | 29 | +15% | ↓3% | AVOID |
| DHR | Danaher Corporation | 29 | +11% | ↓3% | EARLY |
| ELV | Elevance Health Inc. | 29 | +7% | ↓3% | NEUTRAL |
| TMO | Thermo Fisher Scientific Inc. | 29 | +11% | ↓3% | EARLY |
| ABT | Abbott Laboratories | 29 | +14% | ↓3% | EARLY |
Investors who hold ABT may also have indirect exposure through these country funds.
FreeStyle Libre revenue crosses $6B run rate, +20% growth
Abbott Volt pulsed field ablation system gains EP momentum
Estimates · Yahoo Finance · Not audited figures
| Politician | Party | Type | Amount | Trade Date | Return |
|---|---|---|---|---|---|
| Alan Armstrong | Sell | $15k–$50k | Mar 27, 26 | ||
| Rick LarsenWA | Buy | $1k–$15k | Jul 8, 26 | ||
| Richard Dean Dr McCormickGA | Buy | $1k–$15k | Jun 12, 26 | ||
| Gilbert CisnerosCA | Buy | $1k–$15k | Jun 16, 26 | ||
| Julie JohnsonTX | Buy | $1k–$15k | May 12, 26 | ||
| Gilbert CisnerosCA | Buy | $1k–$15k | May 15, 26 | ||
| Richard W. AllenGA | Buy | Unknown amount | Apr 16, 26 | ||
| Josh GottheimerNJ | Sell | $1k–$15k | May 27, 26 | ||
| Laura FriedmanCA | D | Buy | $1k–$15k | Mar 24, 26 | -11.6% |
| Richard Dean Dr McCormickGA | R | Buy | $1k–$15k | Mar 19, 26 | -15.4% |
| Gilbert CisnerosCA | D | Sell | $1k–$15k | Feb 10, 26 | -23.5% |
| Thomas H. KeanNJ | R | Buy | $1k–$15k | Jan 29, 26 | -23.2% |
| Julie JohnsonTX | D | Buy | $1k–$15k | Dec 18, 25 | -30.3% |
| Julia LetlowLA | R | Buy | $1k–$15k | Dec 8, 25 | -30.4% |
| Julia LetlowLA | R | Buy | $1k–$15k | Oct 23, 24 | -30.4% |
| Gilbert CisnerosCA | D | Sell | $1k–$15k | Dec 19, 25 | -30.5% |
| Byron DonaldsFL | R | Buy | $1k–$15k | Dec 4, 25 | -31.9% |
| Shelley M Capito | Sell | $1k–$15k | Feb 24, 25 | -35.0% | |
| Markwayne Mullin | Sell | $1k–$15k | Jan 8, 25 | -31.4% | |
| Markwayne Mullin | Sell | $15k–$50k | Dec 11, 24 | -22.0% |